News & Events category:
Saint Mary's Hospital

A hormone blood test, developed at MFT can determine the effectiveness of anastrozole, the recommended preventative treatment for post-menopausal women at high risk of developing breast cancer.

Manchester University NHS Foundation Trust's (MFT) innovative approach to enhanced patient care.

Babies at MFT have been part of groundbreaking research which found that a single dose of a treatment for a respiratory infection in infants can help cut hospital admissions by more than 80 per cent.

New research has shown that empowering women to self-manage a common treatment for pelvic organ prolapse leads to fewer complications and could save the NHS more than £560 per patient.

More than 1,100 pregnant women on the North Manchester site of Saint Mary’s Managed Clinical Service, have taken part in a rapid beside test to protect newborns from life-threatening illnesses.

Babies and toddlers with a rare and fatal genetic condition can now receive life-saving treatment on the NHS for the first time.

The UK regulatory authorities have approved the first ever trial of a revolutionary gene therapy for young children diagnosed with Hunter syndrome, a devastating rare lysosomal storage disorder.

ITV Tyne Tees and Granada Reports recently featured the journey of two-year-old Teddi Shaw, who became the first child in the UK to receive NHS life-saving gene therapy treatment, Libmeldy® at MFT.